General
Preferred name
IODOFORM
Synonyms
Iodoformum ()
NSC-26251 ()
P&D ID
PD072316
CAS
75-47-8
Tags
available
drug
Drug Status
withdrawn
approved
investigational
vet_approved
Max Phase
3.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
TOXICITY Oral LD50, dermal LD50, and inhalation LC50 in rat are 355 mg/kg, 1184 mg/kg, and 165 ppm/7h, respectively [MSDS]. Fatal dose of iodoform in humans is estimated to be 2 g [L2646]. Systemic intoxication and severe poisoning, mostly characterized by dermatitis, headache, somnolence, delirium, hallucinations, consciousness disturbances, coma, vomiting, CNS depression, tachycardia, and rapid feeble pulse, may result from excess absorption through wounds and abscesses, or ingestion of large quantities [L2646]. While there is no known antidote for iodoform overdose, supportive and symptomatic treatment is highly recommended [L2646]. ; ; Hepatocellular damage has been observed with iodoform toxicity, where production of both fatty liver and necrosis was seen, as well as lesions of liver membranous cellular components [L2646]. Iodoform induces hepatocellular injury and hepatic lesions in a similar manner to carbon tetrachloride, where cellular membranes may possibly be primary sites of action [A32890].
Compound Sets
7
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
ReFrame library
The Spectrum Collection
External IDs
38
Properties
(calculated by RDKit )
Molecular Weight
393.72
Hydrogen Bond Acceptors
0
Hydrogen Bond Donors
0
Rotatable Bonds
0
Ring Count
0
Aromatic Ring Count
0
cLogP
2.58
TPSA
0.0
Fraction CSP3
1.0
Chiral centers
0.0
Largest ring
0.0
QED
0.44
QED
0.44
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Source data